AL-003

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameAL-003

Drug Alias NameAL-003

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnti-Myeloid cell surface antigen CD33

TargetsMyeloid cell surface antigen CD33

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAlector Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A